Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
40 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research company that offers drug development and clinical services. The companys drug development services comprise clinical development, drug candidate selection, in-licensing and technical due diligence; non-clinical and pre-clinical development; regulatory affairs and consulting; pharmacometrics and PK/PD modelling; pharmaceutical development and others. It offers clinical services such as feasibility, regulatory affairs, project management, clinical monitoring, biometrics, interactive response technology, quality, resourcing and recruitment; and legal services.

Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have

  
Source:
Document ID
GDPH388228D
Industry
Ticker
VENN=IE
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Venn Life Sciences Holdings Plc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Venn Life Sciences Holdings Plc, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Venn Life Sciences Holdings Plc, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Venn Life Sciences Holdings Plc, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Venn Life Sciences Holdings Plc, Medical Devices Deals, 2010 to YTD 201691
Venn Life Sciences Holdings Plc, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Venn Life Sciences Holdings Plc, Pharmaceuticals &Healthcare, Deal Details1224
  Venture Financing121
    InnoVenn Raises USD1 Million in Venture Financing Round121
    Venn Life Sciences Raises US$4 Million In Venture Financing131
    Venn Life Sciences Raises US$3 Million In New Venture Funding Round141
  Partnerships151
    Venn Life Sciences Enters into Partnership with European Biotechnology Company151
    Venn Life Sciences Forms Joint Venture With Cellulac And Biopharmed West161
    Venn Life Sciences Forms Joint Venture In Russia171
  Merger181
    Venn Life Sciences And Encorium Announce Merger181
  Equity Offering191
    Venn Life Sciences to Raise USD5.5 Million in Private Placement of Shares192
    Venn Life Sciences Raises USD3.1 Million in Private Placement of Shares212
    Venn Life Sciences Raises USD1.7 Million in Private Placement of Shares231
    Venn Life Sciences Completes IPO For US$4 Million242
  Acquisition261
    Venn Life Sciences Acquires Kinesis Pharma261
    Venn Life Sciences Acquires Majority Stake in Cardinal Systems271
    Venn Life Sciences Acquires Labskin, SYN1113 And Related Equipment From Evocutis For US$0.35 Million282
    Venn Life Sciences Acquires Medevol, Clinical Research Organization, For US$1 Million301
    Venn Life Sciences To Acquire Majority Stake In CRM Clinical Trials For US$0.8 Million311
    Armscote Investment Company Acquires Venn Life Sciences In Reverse Take-Over Transaction For US$4.63 Million321
    JSS Medical Research Acquires Venn Life Sciences331
    Venn Life Sciences Completes Acquisition Of DCI341
    Venn Life Sciences Acquires UpToYou351
Venn Life Sciences Holdings Plc - Key Competitors361
Key Employees371
Locations And Subsidiaries382
  Head Office381
  Other Locations &Subsidiaries382
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Venn-Life-Sciences-Holdings-Plc-VENN-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25000>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Venn-Life-Sciences-Holdings-Plc-VENN-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25000>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research